Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone OAD versus venlafaxine XR in major depressive disorder
2011-005878-37Phase 3Completed
- Sponsor
- Angelini Pharma
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Trazodone OAD with Venlafaxine XR (2 arms). Primary endpoint: Mean change from baseline in HAMD score at final visit. Started Jun 2012; status: completed.
02
Drugs
trazodonevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2011-005878-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005878-37.